PASG - Passage Bio: Price Reduced But Without Data Does Not Look Convincing
- Passage Bio has failed considerably since I last covered it.
- They have also started or are about to start three trials.
- However, without data, there's no way to come to an investment decision.
For further details see:
Passage Bio: Price Reduced, But Without Data, Does Not Look Convincing